Pharmaceutical preparation for the maturation of prothymocytes
US5236706A · kind A · utility
2Cited by
2References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 16, 1991 |
| Grant date | Aug 17, 1993 |
| Priority date | — |
| Expiry date | Jan 16, 2011 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/975
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention concerns a pharmaceutical preparation comprising the 25K IgE-binding factor (25K IgE-bf) and interleukin-1 (IL-1), and the use of said pharmaceutical preparation for the stimulation of the maturation of prothymocytes, e.g. for the treatment of T cell immunodeficiencies and prothymocyte leukemias.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.